A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Vaginal Atrophy
Interventions: DRUG: estriol|DRUG: Placebo
Sponsor: ITF Research Pharma, S.L.U.
Collaborators: Spanish Breast Cancer Research Group